Detalhe da pesquisa
1.
A Prospective Clinical Trial to Evaluate Mesothelin as a Biomarker for the Clinical Management of Patients With Esophageal Adenocarcinoma.
Ann Surg
; 278(5): e1003-e1010, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37185875